NWQ Investment Management Company’s Impax Laboratories, Inc. IPXL Stock Holding History

NWQ Investment Management Company’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,026,237	Closed	-$13.6M	–	216
2016 Q4	$13.6M	Sell	1,026,237 -42,558	-4%	-$728K	0.18%	123
2016 Q3	$25.3M	Buy	1,068,795 +882,389	+473%	+$23.7M	0.37%	88
2016 Q2	$5.37M	Sell	186,406 -4,254	-2%	-$139K	0.09%	124
2016 Q1	$6.1M	Sell	190,660 -7,718	-4%	-$271K	0.1%	122
2015 Q4	$8.48M	Sell	198,378 -398,241	-67%	-$15.9M	0.13%	112
2015 Q3	$21M	Sell	596,619 -113,683	-16%	-$5.12M	0.32%	91
2015 Q2	$32.3M	Sell	710,302 -225,825	-24%	-$10.7M	0.45%	81
2015 Q1	$43.9M	Buy	936,127 +30,084	+3%	+$1.2M	0.55%	70
2014 Q4	$28.7M	Sell	906,043 -392,952	-30%	-$11.5M	0.34%	82
2014 Q3	$30.7M	Buy	1,298,995 +314,154	+32%	+$8.05M	0.34%	79
2014 Q2	$29.5M	Buy	+984,841	New	+$26.6M	0.3%	79

Other funds holding IPXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

NWQ Investment Management Company's IPXL Position: Q1 2017 in Review

NWQ Investment Management Company sold out of Impax Laboratories, Inc. (IPXL) in Q1 2017, closing a stake of 1,026,237 shares — an estimated $13.6M sold.

NWQ Investment Management Company first reported a position in IPXL in Q2 2014 and held it in 11 quarters. The position peaked at $43.9M in Q1 2015. 178 funds tracked by Wall St. Rank hold IPXL as of Q1 2017.

NWQ Investment Management Company reported no remaining Impax Laboratories, Inc. position as of Q1 2017 after selling out during the quarter.
NWQ Investment Management Company sold 1,026,237 Impax Laboratories, Inc. shares in Q1 2017, an estimated $13.6M.
NWQ Investment Management Company first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 11 quarters.
NWQ Investment Management Company's Impax Laboratories, Inc. position peaked at $43.9M in Q1 2015.
178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2017.

Based on NWQ Investment Management Company's 13F filing for Q1 2017, filed 15 May 2017.